GENE CRITICAL LOOKING TO NETWORK PATHWAYS TO IMPROVE GENOMIC TESTING
BIOLOGICAL PATHWAY DISCOVERY TO ALIGN TREATMENT OPTIONS REQUIRES A NETWORKED SYSTEM
Gene Critical a start-up focused on understanding how to improve the speed and alignment of consumer genomic testing,
A Focus on Cancer, Rare disease & Longevity.
GENE CRITICAL was founded by rare cancer advocate Professor Craig McLachlan.
OBSERVATIONS
Genomic testing can help identify unique and druggable targets in disease if mutations or disease-causing gene pathways can be identified.
Not all genomic services are alike, how to navigate across and between different systems can be problematic for the doctor and patient.
At GENE CRITICAL, we are building a membership network that will test the ability to map and connect time critical points in the genomic testing journey.
“
I have a NRAS mutation driving a rare hematological cancer - time from first biopsy to gene mutation discovery 18 months delaying treatment for 2 years.
-Craig McLachlan (Founder / CEO)